In the current study, we investigated the expression of 11ßHSD2 in lung cancers and whether inhibition of 11ßHSD2 activity could suppress lung tumorigenesis due to increased tumor cell intracellular active glucocorticoids and subsequent inhibition of COX-2 expression/activity. The gene discussed is PTGS2; the disease is lung carcinoma.